EVALUATION OF AGREEMENT BETWEEN ENDOSCOPIC AND HISTOPATHOLOGY RESULTS FOR THE DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE

Đào Việt Hằng, Vũ Việt Sơn, Trần Thị Thu Trang, Đào Thị Luận

Main Article Content

Abstract

Introduction: Inflammatory bowel disease (IBD) is a disease with complicating pathophysiology and increasing prevalence worldwide. Diagnosis of IBD, especially in atypical cases, is based on the combination of clinical symptoms, endoscopic and histopathology results. Our study aimed to evaluate the level of agreement on the diagnosis of IBD between endoscopic and histopathology results. Methods: a descriptive retrospective study was conducted at Hanoi Medical University Hospital from February 2020 to October 2020 in patients who had endoscopy images suspected of ulcerative colistis (UC) or Crohn's diseases and had histopathology reports. The biopsy samples were examined independently by a histopathologist specialized in IBD in second round; the expert’s reports were compared with the first reports and the endoscopic results. Results: 46 patients met the selection criteria, the mean age was 44.23 (14.5), min-max was 19-74, the female/male ratio was 1.3. On endoscopy, 89.1% of patients were diagnosed with UC, only 5 patients were diagnosed with Crohn’s disease (10.9%). The levels of agreement between the endoscopy results and the first and the second histopathology reports were poor and moderate with κ coefficients of 0.265 and 0.491, respectively. The level of aggrement between the first and the second histopatholoy reports was moderate (κ = 0.487). Conclusion: The levels of aggrement between endoscopic results and histopathology results with and without expert opinion were low and medium (κ <0.6).

Article Details

References

1. Actis, G.C., et al., History of Inflammatory Bowel Diseases. J Clin Med, 2019. 8(11).
2. Ng, S.C., et al., Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet, 2018. 390(10114): p. 2769-2778.
3. Flynn, S. and S. Eisenstein, Inflammatory Bowel Disease Presentation and Diagnosis. Surg Clin North Am, 2019. 99(6): p. 1051-1062.
4. Maaser, C., et al., ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. Journal of Crohn's and Colitis, 2019. 13(2): p. 144-164K.
5. Magro, F., et al., European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis, 2013. 7(10): p. 827-51.
6. Annese, V., et al., European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis, 2013. 7(12): p. 982-1018.
7. Gajendran, M., et al., A comprehensive review and update on Crohn's disease. Dis Mon, 2018. 64(2): p. 20-57.
8. Gajendran, M., et al., A comprehensive review and update on ulcerative colitis(). Dis Mon, 2019. 65(12): p. 100851.
9. Feakins, R.M. and G. British Society of, Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines. J Clin Pathol, 2013. 66(12): p. 1005-26.
10. M'Koma, A.E., Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol, 2013. 6: p. 33-47.